Atossa Therapeutics
ATOS
#10053
Rank
โ‚น3.88 B
Marketcap
โ‚น451.24
Share price
-2.20%
Change (1 day)
439.34%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น24.13. In 2024 the company made an earnings per share (EPS) of -โ‚น19.30 an increase over its 2023 EPS that were of -โ‚น23.17.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5211.49%
2024-โ‚น19.30-16.67%
2023-โ‚น23.1714.29%
2022-โ‚น20.2716.67%
2021-โ‚น17.37-90.86%
2020-โ‚น190.15-2.96%
2019-โ‚น195.94-63.09%
2018-โ‚น530.87-49.63%
2017-โ‚น1,054-57.87%
2016-โ‚น2,502-74.01%
2015-โ‚น9,625-9.18%
2014-โ‚น10,598-12.86%
2013-โ‚น12,16270.73%
2012-โ‚น7,12334.08%
2011-โ‚น5,313263.47%
2010-โ‚น1,462

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.25-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น885.11-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,096-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น59.84 148.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น20.27-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA